Found 0 matching trials
Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis
PHASE1This trial is conducted in Europe. The aim of this trial is to to evaluate ...
Location
Novo Nordisk Investigational Site
The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder
PHASE4Menopausal syndromes includes somatic symptom, psychosomatic symptoms, sexu...
Location
Far Eastern Memorial Hospital
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer
NARATIONALE: Estrogen can cause the growth of tumor cells. Hormone therapy us...
Location
University of Arizona Cancer Center
A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles
PHASE3The main objective of this trial is to demonstrate the contraceptive effica...
Location
Fellows Research Alliance, Inc.
Stopping Heavy Periods Project
NAThis study is a randomized clinical trial comparing the effectiveness of th...
Location
Gynecologic practices affiliated with Women and Infants Hospital
Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive
PHASE4This double-blinded, placebo-controlled, randomized trial will compare the ...
Location
University of California, Davis Department of Obstetrics and Gynecology
Pharmacokinetics of Injectable Estradiol and Progesterone Microspheres Suspension
PHASE1Phase I pharmacokinetic study
Main objective:
To determine plasmatic prof...
Location
Asociación Mexicana para la Investigación Clínica, A. C. (AMIC)
Administration of Oral Contraceptives at Different Times of the Follicular Phase of the Menstrual Cycle
NAWe hypothesize that administration of OCs at varying follicular diameters w...
Location
Ob-Gyn Royal University Hospital
Fulvestrant 500mg in Patients With Advanced Breast Cancer
N/AFulvestrant 500mg in Patients With Advanced Breast Cancer...
Location
Fudan University Cancer Hospital
Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Fasting Conditions.
PHASE1This study was designed to compare the relative bioavailability (rate and e...
Location
PRACS Institute, Ltd.